Cerus Corporation
2411 Stanwell Drive
Concord,
CA 94520
United States - Map
Phone: 925-288-6000
Fax: 925-288-6001
Web Site: http://www.cerus.com
| Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System. The companys INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. It markets the INTERCEPT system for platelets and plasma primarily in Europe, the Russian Federation, and the Middle East. The company is also developing INTERCEPT Blood System for red blood cells or red blood cell system, which is designed to inactivate blood-borne pathogens in donated red blood cells for transfusion. It has collaboration agreements with Baxter International, Inc., BioOne Corporation, and Laboratorios Grifols S.A., as well as the United States Armed Forces. The company was founded in 1991 and is based in Concord, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Claes Glassell M.Sc., 58
Chief Exec. Officer, Pres |
$
486.00K |
$
0 | Dr. Laurence M. Corash M.D., 64
Co-Founder, Chief Medical Officer, Chief Scientific Officer, Sr. VP |
$
373.00K |
$
0 | Mr. Howard G. Ervin , 61
VP of Legal Affairs |
$
309.00K |
$
0 | Mr. William M. Greenman , 42
Sr. VP of Bus. Devel. and Marketing |
$
310.00K |
$
0 | Mr. Kevin D. Green ,
Chief Accounting Officer and VP of Fin. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.09% Nasdaq 
Profile
